Literature DB >> 25867650

Outcomes for HIV-positive patients with primary central nervous system lymphoma after high-dose chemotherapy and auto-SCT.

A O'Neill1, K Mikesch2, K Fritsch3, B Kasenda2, L Banerjee1, F Burns4, G Zakout1, R Johnston5, G Illerhaus2, K Cwynarski1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25867650     DOI： 10.1038/bmt.2015.18

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  14 in total

1.  Clinical presentation, treatment, and outcomes among 65 patients with HIV-associated lymphoma treated at the University of North Carolina, 2000-2010.

Authors:  Satish Gopal; Kelly E Martin; Kristy L Richards; Joseph J Eron
Journal:  AIDS Res Hum Retroviruses       Date:  2011-12-01       Impact factor: 2.205

Review 2.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.

Authors:  Therese A Dolecek; Jennifer M Propp; Nancy E Stroup; Carol Kruchko
Journal:  Neuro Oncol       Date:  2012-11       Impact factor: 12.300

3.  Successful treatment of AIDS-associated, primary CNS lymphoma with rituximab- and methotrexate-based chemotherapy and autologous stem cell transplantation.

Authors:  T Wolf; T Kiderlen; J Atta; C Stephan; G Kann; H-R Brodt; C Brandts
Journal:  Infection       Date:  2014-01-20       Impact factor: 3.553

Review 4.  Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges.

Authors:  Paul G Rubinstein; David M Aboulafia; Andrew Zloza
Journal:  AIDS       Date:  2014-02-20       Impact factor: 4.177

5.  Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group.

Authors:  T R Coté; A Manns; C R Hardy; F J Yellin; P Hartge
Journal:  J Natl Cancer Inst       Date:  1996-05-15       Impact factor: 13.506

6.  High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.

Authors:  Andrés J M Ferreri; Michele Reni; Marco Foppoli; Maurizio Martelli; Gerasimus A Pangalis; Maurizio Frezzato; Maria Giuseppina Cabras; Alberto Fabbri; Gaetano Corazzelli; Fiorella Ilariucci; Giuseppe Rossi; Riccardo Soffietti; Caterina Stelitano; Daniele Vallisa; Francesco Zaja; Lucía Zoppegno; Gian Marco Aondio; Giuseppe Avvisati; Monica Balzarotti; Alba A Brandes; José Fajardo; Henry Gomez; Attilio Guarini; Graziella Pinotti; Luigi Rigacci; Catrina Uhlmann; Piero Picozzi; Paolo Vezzulli; Maurilio Ponzoni; Emanuele Zucca; Federico Caligaris-Cappio; Franco Cavalli
Journal:  Lancet       Date:  2009-09-18       Impact factor: 79.321

7.  Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation.

Authors:  Elisabeth Schorb; Benjamin Kasenda; Johannes Atta; Stephan Kaun; Anke Morgner; Georg Hess; Thomas Elter; Nikolas von Bubnoff; Martin Dreyling; Mark Ringhoffer; Stefan W Krause; Günter Derigs; Beate Klimm; D Niemann; Kristina Fritsch; Jürgen Finke; Gerald Illerhaus
Journal:  Haematologica       Date:  2013-01-08       Impact factor: 9.941

8.  Autologous stem-cell transplantation in patients with HIV-related lymphoma.

Authors:  Pascual Balsalobre; José L Díez-Martín; Alessandro Re; Mariagrazia Michieli; José M Ribera; Carmen Canals; Anne Rosselet; Eulogio Conde; Rosario Varela; Kate Cwynarski; Ian Gabriel; Philippe Genet; Gaelle Guillerm; Bernardino Allione; Augustin Ferrant; Pierre Biron; Ildefonso Espigado; David Serrano; Anna Sureda
Journal:  J Clin Oncol       Date:  2009-03-30       Impact factor: 44.544

9.  Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation.

Authors:  José L Díez-Martín; Pascual Balsalobre; Alessandro Re; Mariagrazia Michieli; José M Ribera; Carmen Canals; Eulogio Conde; Anne Rosselet; Ian Gabriel; Rosario Varela; Bernardino Allione; Kate Cwynarski; Philippe Genet; Ildefonso Espigado; Pierre Biron; Norbert Schmitz; Anne E Hunter; Augustin Ferrant; Gaelle Guillerm; Mark Hentrich; Manuel Jurado; Pascual Fernández; David Serrano; Giuseppe Rossi; Anna Sureda
Journal:  Blood       Date:  2009-03-23       Impact factor: 22.113

10.  Primary CNS lymphoma in HIV positive and negative patients: comparison of clinical characteristics, outcome and prognostic factors.

Authors:  Soley Bayraktar; Ulas D Bayraktar; Juan C Ramos; Alexandra Stefanovic; Izidore S Lossos
Journal:  J Neurooncol       Date:  2010-06-06       Impact factor: 4.506
View more
  3 in total

1.  High-dose chemotherapy and autologous stem cell transplantation for primary central nervous system lymphoma: a multi-centre retrospective analysis from the United Kingdom.

Authors:  S Kassam; E Chernucha; A O'Neill; C Hemmaway; T Cummins; S Montoto; A Lennard; G Adams; K Linton; P McKay; D Davies; C Rowntree; S Easdale; T A Eyre; R Marcus; K Cwynarski; C P Fox
Journal:  Bone Marrow Transplant       Date:  2017-06-05       Impact factor: 5.483

Review 2.  Central Nervous System Lymphoma: Novel Therapies.

Authors:  Shannon P Fortin Ensign; Diamone Gathers; Julia Erin Wiedmeier; Maciej M Mrugala
Journal:  Curr Treat Options Oncol       Date:  2022-02-19

Review 3.  Opportunistic Neurologic Infections in Patients with Acquired Immunodeficiency Syndrome (AIDS).

Authors:  Fritzie Albarillo; Paul O'Keefe
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.